JCEM: NAFLD and liver fibrosis have nothing to do with femoral bone density reduction

Whether non-alcoholic fatty liver disease (NAFLD) may be a risk factor for lowering bone mineral density (BMD) is still controversial, and whether liver fibrosis is the main predictor of future liver-related events in NAFLD patients is not yet clear.

Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.

In the population-based cross-sectional analysis of the National Health and Nutrition Examination (NHANES) from 2017 to 2018, the researchers used both the vibration-controlled transient elastography (VCTE) of the femoral neck and the dual-energy X-ray bone densitometer ( DXA) for testing.

The results of the study show that stearic degeneration and obvious fibrosis are very common in the population, accounting for 53.

It can be seen that in people over 50 years old in the United States, liver steatosis and fibrosis have nothing to do with the diagnosis of osteopenia or osteoporosis based on femoral DXA .

Original source:

Stefano Ciardullo.